(Q64637406)

English

Ambrisentan for Treatment of Portopulmonary Hypertension

clinical trial

Statements

Ambrisentan for Treatment of Portopulmonary Hypertension (PoPH): a Pilot Study (English)
0 references
0 references
July 2012
0 references
April 2016
0 references
0
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit